Small RNAs might drive COPD progression: Research lays foundation for potential new diagnostics and therapies
Chronic obstructive pulmonary disease (COPD) affects nearly 12 million people in the U.S. alone and is the third leading cause of death worldwide. High levels of immune molecules known as cytokines, which can damage the lungs, ...